ImmunoPrecise Antibodies Ltd. Files 6-K Report
Ticker: HYFT · Form: 6-K · Filed: Jun 24, 2025 · CIK: 1715925
Sentiment: neutral
Topics: filing, press-release
TL;DR
IPA files 6-K, press release attached. Details inside.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on June 24, 2025, to report a press release dated June 24, 2025. The filing does not contain specific financial figures or operational details beyond the announcement of the press release itself.
Why It Matters
This filing indicates ImmunoPrecise Antibodies Ltd. is providing an update to the market, likely containing new information relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to attach a press release, with no immediate indication of significant financial or operational changes.
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Filer of the report
- June 24, 2025 (date) — Date of the press release and filing
- Jennifer Bath (person) — Signatory for the company
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose of this 6-K filing is to report a press release dated June 24, 2025, issued by ImmunoPrecise Antibodies Ltd.
What is the filing date of this Form 6-K?
This Form 6-K was filed on June 24, 2025.
Who is the signatory for ImmunoPrecise Antibodies Ltd. on this report?
Jennifer Bath is the signatory for ImmunoPrecise Antibodies Ltd. on this report.
What is the SEC file number for ImmunoPrecise Antibodies Ltd.?
The SEC file number for ImmunoPrecise Antibodies Ltd. is 001-39530.
What exhibit is included with this 6-K filing?
Exhibit 99.1, a Press Release dated June 24, 2025, is included with this 6-K filing.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 24, 2025 by Jennifer Bath regarding ImmunoPrecise Antibodies Ltd. (HYFT).